<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cancer drugs</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>'Octopus' provides cancer breakthrough</title>
   	 <description>A breakthrough in understanding a biological process that causes many common cancers including lung and breast cancer opens up a whole new realm of possibilities for the development of improved cancer drugs. The results are featured on the front cover of the journal Molecular and Cellular Biology published today.</description>
	  <link>http://medicalxpress.com/news/2011-05-octopus-cancer-breakthrough.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 13 May 2011 06:25:38 EST</pubDate>
	 <guid isPermaLink="false">news224486698</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/octopusprovi.jpg" width="90" height="90" />
</item>
<item>
     <title>'Fasting pathway' points the way to new class of diabetes drugs</title>
   	 <description>A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.</description>
	  <link>http://medicalxpress.com/news/2011-05-fasting-pathway-class-diabetes-drugs.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 12 May 2011 12:25:32 EST</pubDate>
	 <guid isPermaLink="false">news224421912</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/fastingpathw.jpg" width="90" height="85" />
</item>
<item>
     <title>Researchers explain why cancer 'smart drugs' may not be so smart</title>
   	 <description>(Medical Xpress) -- Some of the most effective and expensive cancer drugs, dubbed &quot;smart drugs&quot; for their ability to stop tumors by targeting key drivers of cancer cell growth, are not effective in some patients. In two related studies, Yale School of Medicine researchers examined one such driver, the EGF receptor (EGFR), and found that a decoy receptor might be limiting the amount of drug that gets to the intended target.</description>
	  <link>http://medicalxpress.com/news/2011-05-cancer-smart-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 11 May 2011 05:39:02 EST</pubDate>
	 <guid isPermaLink="false">news224311055</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/1-researcherse.jpg" width="90" height="90" />
</item>
<item>
     <title>Heat helps cancer drugs battle cancer</title>
   	 <description>(PhysOrg.com) -- Localized hyperthermia has been used occasionally with cancer drugs for some time, but until now, the reason it helps has been a mystery.  In a report in the Proceedings of the National Academy of Sciences, scientists have discovered that the addition of heat inhibits homologous recombination so the cancer cells are unable to repair DNA damage caused by the cancer treatments.</description>
	  <link>http://medicalxpress.com/news/2011-05-cancer-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 10 May 2011 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news224255592</guid>
	 
</item>


</channel>
</rss>
